Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced an expanded Series A and new appointments to its executive leadership team, board of ...
Through the collaboration, Applied StemCell is providing Syntax Bio with iPSC lines, including its GMP-compatible hypoimmune iPSC platform, which combines immune-evasion genome engineering with ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, and Ajinomoto Health & Nutrition North America, Inc. (AHN), a leader in amino acid science and cell culture ...
Syntax Bio expands Series A to $14.4M to boost CRISPR Cellgorithm platform and type 1 diabetes beta-cell therapy amid tough biotech funding—read more.
Local AI inference at 32B-parameter quality, no cloud API required: University of Waterloo researchers released PAW on July 2 ...
The path from block-based programming to vibe coding represents a shift from mastering the mechanics of implementation to ...
A pre-wedding video showing Pune realtor Ketan Agarwal joyfully celebrating with his fiancée Siya Goyal and her parents has ...
The hottest new programming language is English. Andrej Karpathy, OpenAI co-founder and former Tesla AI director, said this ...
Delve into the Open Building approach, promoting long-term stewardship and adaptability in architecture amid today's housing ...
Python’s lead narrows again, C holds the runner-up spot, C++ returns to third, and SQL climbs back above R in June’s top 10 ...
The Transportation Security Administration is initiating a new screening program for crew members, and airlines are paying ...
Phase 1/2 FUNCTION ALS trial initiated in Europe with additional global regions anticipated in 2026 First patients dosed in LAUNCH ALS, an investigator-initiated trial in China conducted in partnershi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results